TP receptor-mediated release of eosinophil chemotactic activity from human bronchial smooth muscle cells

Yusuke Suzuki, Koichiro Asano, Kyoko Niimi, Jun Miyata, Yoshiki Shiraishi, Koichi Fukunaga, Tetsuya Shiomi, Takeshi Nakajima, Tsuyoshi Oguma, Koichi Sayama, Akitoshi Ishizaka

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

There are reports indicating that thromboxane A2 receptors (TP receptors) may stimulate the eosinophil accumulation in the lower airways of asthmatics, however, the mechanisms behind such an effect remain unknown. We quantified the synthesis of eosinophil chemotactic activity and eosinophilic CC chemokines, including CCL5, CCL7, CCL8, CCL11, CCL13, CCL24, and CCL26 in primary cultures of human bronchial smooth muscle cells (BSMC) stimulated with a prostanoid TP receptor agonist, IBOP (10- 9-10- 7 M). The activation of prostanoid TP receptors in BSMC induced the release of potent eosinophil chemoattractant(s) in the presence of interleukin (IL)-4. CCL11/eotaxin-1 was the only synthesis significantly increased by IBOP co-stimulated with IL-4, and pretreatment with an anti-CCL11 antibody abrogated the eosinophil chemotactic activity released from IBOP/IL-4-stimulated BSMC. The effect of IBOP was also completely blocked by pretreatment with a prostanoid TP receptor-specific antagonist, AA-2414. IBOP had no effect on the expression of IL-4 receptor-α, or on the IL-4-induced phosphorylation of STAT6 in BSMC. In conclusion, activation of prostanoid TP receptors in a Th2-dominant microenvironment might exacerbate the eosinophilic inflammation of the airways by synthesis and release of CCL11 from BSMC.

Original languageEnglish
Pages (from-to)133-139
Number of pages7
JournalEuropean Journal of Pharmacology
Volume600
Issue number1-3
DOIs
Publication statusPublished - 2008 Dec 14

Fingerprint

Thromboxane Receptors
Eosinophils
Human Activities
Smooth Muscle Myocytes
Interleukin-4
Prostaglandins
seratrodast
Chemokine CCL11
Interleukin-4 Receptors
Prostaglandin H2 Receptors Thromboxane A2
Chemokine CCL5
CC Chemokines
Chemotactic Factors
Anti-Idiotypic Antibodies
Phosphorylation
Inflammation

Keywords

  • Asthma
  • CCL11
  • CCR3
  • Chemotaxis
  • Interleukin-4

ASJC Scopus subject areas

  • Pharmacology

Cite this

TP receptor-mediated release of eosinophil chemotactic activity from human bronchial smooth muscle cells. / Suzuki, Yusuke; Asano, Koichiro; Niimi, Kyoko; Miyata, Jun; Shiraishi, Yoshiki; Fukunaga, Koichi; Shiomi, Tetsuya; Nakajima, Takeshi; Oguma, Tsuyoshi; Sayama, Koichi; Ishizaka, Akitoshi.

In: European Journal of Pharmacology, Vol. 600, No. 1-3, 14.12.2008, p. 133-139.

Research output: Contribution to journalArticle

Suzuki, Y, Asano, K, Niimi, K, Miyata, J, Shiraishi, Y, Fukunaga, K, Shiomi, T, Nakajima, T, Oguma, T, Sayama, K & Ishizaka, A 2008, 'TP receptor-mediated release of eosinophil chemotactic activity from human bronchial smooth muscle cells', European Journal of Pharmacology, vol. 600, no. 1-3, pp. 133-139. https://doi.org/10.1016/j.ejphar.2008.09.044
Suzuki, Yusuke ; Asano, Koichiro ; Niimi, Kyoko ; Miyata, Jun ; Shiraishi, Yoshiki ; Fukunaga, Koichi ; Shiomi, Tetsuya ; Nakajima, Takeshi ; Oguma, Tsuyoshi ; Sayama, Koichi ; Ishizaka, Akitoshi. / TP receptor-mediated release of eosinophil chemotactic activity from human bronchial smooth muscle cells. In: European Journal of Pharmacology. 2008 ; Vol. 600, No. 1-3. pp. 133-139.
@article{4ba92c5c3e3a4318898b1a6f8a77148d,
title = "TP receptor-mediated release of eosinophil chemotactic activity from human bronchial smooth muscle cells",
abstract = "There are reports indicating that thromboxane A2 receptors (TP receptors) may stimulate the eosinophil accumulation in the lower airways of asthmatics, however, the mechanisms behind such an effect remain unknown. We quantified the synthesis of eosinophil chemotactic activity and eosinophilic CC chemokines, including CCL5, CCL7, CCL8, CCL11, CCL13, CCL24, and CCL26 in primary cultures of human bronchial smooth muscle cells (BSMC) stimulated with a prostanoid TP receptor agonist, IBOP (10- 9-10- 7 M). The activation of prostanoid TP receptors in BSMC induced the release of potent eosinophil chemoattractant(s) in the presence of interleukin (IL)-4. CCL11/eotaxin-1 was the only synthesis significantly increased by IBOP co-stimulated with IL-4, and pretreatment with an anti-CCL11 antibody abrogated the eosinophil chemotactic activity released from IBOP/IL-4-stimulated BSMC. The effect of IBOP was also completely blocked by pretreatment with a prostanoid TP receptor-specific antagonist, AA-2414. IBOP had no effect on the expression of IL-4 receptor-α, or on the IL-4-induced phosphorylation of STAT6 in BSMC. In conclusion, activation of prostanoid TP receptors in a Th2-dominant microenvironment might exacerbate the eosinophilic inflammation of the airways by synthesis and release of CCL11 from BSMC.",
keywords = "Asthma, CCL11, CCR3, Chemotaxis, Interleukin-4",
author = "Yusuke Suzuki and Koichiro Asano and Kyoko Niimi and Jun Miyata and Yoshiki Shiraishi and Koichi Fukunaga and Tetsuya Shiomi and Takeshi Nakajima and Tsuyoshi Oguma and Koichi Sayama and Akitoshi Ishizaka",
year = "2008",
month = "12",
day = "14",
doi = "10.1016/j.ejphar.2008.09.044",
language = "English",
volume = "600",
pages = "133--139",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - TP receptor-mediated release of eosinophil chemotactic activity from human bronchial smooth muscle cells

AU - Suzuki, Yusuke

AU - Asano, Koichiro

AU - Niimi, Kyoko

AU - Miyata, Jun

AU - Shiraishi, Yoshiki

AU - Fukunaga, Koichi

AU - Shiomi, Tetsuya

AU - Nakajima, Takeshi

AU - Oguma, Tsuyoshi

AU - Sayama, Koichi

AU - Ishizaka, Akitoshi

PY - 2008/12/14

Y1 - 2008/12/14

N2 - There are reports indicating that thromboxane A2 receptors (TP receptors) may stimulate the eosinophil accumulation in the lower airways of asthmatics, however, the mechanisms behind such an effect remain unknown. We quantified the synthesis of eosinophil chemotactic activity and eosinophilic CC chemokines, including CCL5, CCL7, CCL8, CCL11, CCL13, CCL24, and CCL26 in primary cultures of human bronchial smooth muscle cells (BSMC) stimulated with a prostanoid TP receptor agonist, IBOP (10- 9-10- 7 M). The activation of prostanoid TP receptors in BSMC induced the release of potent eosinophil chemoattractant(s) in the presence of interleukin (IL)-4. CCL11/eotaxin-1 was the only synthesis significantly increased by IBOP co-stimulated with IL-4, and pretreatment with an anti-CCL11 antibody abrogated the eosinophil chemotactic activity released from IBOP/IL-4-stimulated BSMC. The effect of IBOP was also completely blocked by pretreatment with a prostanoid TP receptor-specific antagonist, AA-2414. IBOP had no effect on the expression of IL-4 receptor-α, or on the IL-4-induced phosphorylation of STAT6 in BSMC. In conclusion, activation of prostanoid TP receptors in a Th2-dominant microenvironment might exacerbate the eosinophilic inflammation of the airways by synthesis and release of CCL11 from BSMC.

AB - There are reports indicating that thromboxane A2 receptors (TP receptors) may stimulate the eosinophil accumulation in the lower airways of asthmatics, however, the mechanisms behind such an effect remain unknown. We quantified the synthesis of eosinophil chemotactic activity and eosinophilic CC chemokines, including CCL5, CCL7, CCL8, CCL11, CCL13, CCL24, and CCL26 in primary cultures of human bronchial smooth muscle cells (BSMC) stimulated with a prostanoid TP receptor agonist, IBOP (10- 9-10- 7 M). The activation of prostanoid TP receptors in BSMC induced the release of potent eosinophil chemoattractant(s) in the presence of interleukin (IL)-4. CCL11/eotaxin-1 was the only synthesis significantly increased by IBOP co-stimulated with IL-4, and pretreatment with an anti-CCL11 antibody abrogated the eosinophil chemotactic activity released from IBOP/IL-4-stimulated BSMC. The effect of IBOP was also completely blocked by pretreatment with a prostanoid TP receptor-specific antagonist, AA-2414. IBOP had no effect on the expression of IL-4 receptor-α, or on the IL-4-induced phosphorylation of STAT6 in BSMC. In conclusion, activation of prostanoid TP receptors in a Th2-dominant microenvironment might exacerbate the eosinophilic inflammation of the airways by synthesis and release of CCL11 from BSMC.

KW - Asthma

KW - CCL11

KW - CCR3

KW - Chemotaxis

KW - Interleukin-4

UR - http://www.scopus.com/inward/record.url?scp=55949107827&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55949107827&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2008.09.044

DO - 10.1016/j.ejphar.2008.09.044

M3 - Article

C2 - 18950617

AN - SCOPUS:55949107827

VL - 600

SP - 133

EP - 139

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-3

ER -